Cargando…
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters
The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological advances, other innovative biologics, such as...
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889098/ https://www.ncbi.nlm.nih.gov/pubmed/33557682 http://dx.doi.org/10.1080/19420862.2020.1868078 |